Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

Prevention of Venous Thromboembolism in 2020 and Beyond

dc.contributor.authorNicholson M
dc.contributor.authorChan N
dc.contributor.authorBhagirath V
dc.contributor.authorGinsberg J
dc.date.accessioned2021-06-07T15:34:34Z
dc.date.available2021-06-07T15:34:34Z
dc.date.issued2020-08-01
dc.date.updated2021-06-07T15:34:33Z
dc.description.abstract<jats:p>Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.</jats:p>
dc.identifier.doihttps://doi.org/10.3390/jcm9082467
dc.identifier.issn2077-0383
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/11375/26512
dc.publisherMDPI AG
dc.rightsAttribution - CC BY This Creative Commons license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. Recommended for maximum dissemination and use of licensed materials.
dc.rights.licenseAttribution - CC BY
dc.rights.uri2
dc.subjectCOVID
dc.subjectDVT
dc.subjectPE
dc.subjectVTE
dc.subjectcancer
dc.subjectepidemiology
dc.subjectprevention
dc.subjectprophylaxis
dc.titlePrevention of Venous Thromboembolism in 2020 and Beyond
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prevention of Venous Thromboembolism in 2020 and Beyond.pdf
Size:
732.91 KB
Format:
Adobe Portable Document Format
Description:
Published version